Acuta Capital Partners, LLC Clovis Oncology, Inc. Transaction History
Acuta Capital Partners, LLC
- $98.8 Million
- Q3 2024
A detailed history of Acuta Capital Partners, LLC transactions in Clovis Oncology, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 80,000 shares of CLVS stock, worth $7,200. This represents 1.18% of its overall portfolio holdings.
Number of Shares
80,000Holding current value
$7,200% of portfolio
1.18%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CLVS
# of Institutions
1Shares Held
166Call Options Held
0Put Options Held
0About Clovis Oncology, Inc.
- Ticker CLVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 144,480,000
- Market Cap $13M
- Description
- Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...